Australia Joins Global Effort to Detect Pancreatic Cancer Earlier

October 7, 2025
Precede Foundation

A major step forward in early detection is underway: the Jreissati Pancreatic Centre at Epworth (Melbourne) and Pankind, Pancreatic Cancer Australia, have launched APRISE—a national high-risk pancreatic cancer screening program and registry. The program will evaluate how best to find pancreatic cancer earlier among people with increased risk due to family history or genetics and has already secured participation from leading hospitals across every Australian state and territory.

Why this matters: pancreatic cancer remains one of the deadliest cancers largely because it’s often diagnosed late. APRISE is designed to shift that timeline—catching disease earlier, improving treatment options, and ultimately saving lives. Importantly, the partnership also connects Australia to the Pancreatic Cancer Early Detection (PRECEDE) study, a global consortium based at UC San Diego with 30+ international sites. This expansion strengthens the shared data and screening protocols that PRECEDE exists to develop, accelerating discoveries that benefit patients worldwide.

Pankind will contribute $500,000 over five years to support the study and has introduced a quick Family Risk Checker (about three minutes) to help Australians understand their personal risk and next steps. As APRISE enrolls high-risk individuals nationally, PRECEDE’s global network will integrate those data to refine who should be screened, when, and with which tools—core questions at the heart of preventing late-stage diagnoses.

What you can do:

  • If you are in Australia and have a family history or known genetic risk, consider using Pankind’s Family Risk Checker and speak with your clinician about APRISE.

  • Wherever you live, support research and education efforts that advance earlier detection. Progress happens faster when health systems and nonprofits work together across borders—exactly what this Australia–PRECEDE collaboration is designed to achieve.

Knowing When To Ask For Help

There’s strength in recognizing when you need additional support. If you’re feeling consistently overwhelmed, anxious, or depressed, it may be time to speak with a healthcare professional. Warning signs can include ongoing sleep trouble, loss of appetite, or emotional numbness.

Mental health care is an important part of cancer recovery. There are therapists, social workers, and cancer-specific counselors trained to support your unique needs. Don’t hesitate to seek them out.

Your medical team can help adjust medications or recommend physical therapy if your symptoms are impacting your daily life. Being honest about your struggles allows your care providers to offer better, more personalized support.

The path to recovery from pancreatic cancer is rarely straightforward. It’s a mix of triumphs and setbacks, strength and vulnerability. But through each high and low, healing is happening. Be gentle with yourself. Allow space for rest, reflection, and growth.

You don’t have to go through this journey alone. With the right support, emotional, physical, and practical, you can move forward, one step at a time. And remember, every day you show up for yourself is a victory.

At TrovaNOW, we’re focused on finding a cure for pancreatic cancer. Every test and discovery brings us closer to better treatments and saving lives. Join us and learn more at TrovaNOW.

Australia Joins Global Effort to Detect Pancreatic Cancer Earlier

A major step forward in early detection is underway: the...

Visual related to the power of genetic testing in pancreatic cancer screening

A Promising Vaccine Approach Targeting KRAS Mutations in Pancreatic and Colorectal Cancer

Cancer treatment has long sought ways to harness the immune...

Visual related to pancreatic cancer & genetics: what you need to know

PRECEDE Reaches 10,000 Participants in Global Pancreatic Cancer Study

The world’s largest collaborative effort in pancreatic cancer early detection...

Inaugural Gala

October 28, 2025 | 6pm-10pm | Tribeca Rooftop

Your donation directly supports this groundbreaking work, including the infrastructure, scientific collaborations, and patient-focused efforts that are accelerating early detection tools with the potential to raise survival rates from 13% to 50%.